Kristin Fabre

Kristin Fabre joined NASA’s Human Research Program (HRP) in January 2022. She works with HRP leadership, managers, and scientists to set research strategies and ensure a robust scientific portfolio that mitigates human spaceflight hazards. 

Before joining HRP, Fabre served as chief scientist at the Translational Research Institute for Space Health (TRISH). There, Fabre led the effort to invest in high-risk, high-reward research and technology for space exploration. She worked with NASA, the industry, and academia as TRISH stakeholders to adopt and implement deliverables. 

Prior to TRISH, Fabre served as the micro-physiological systems lead at the pharmaceutical company AstraZeneca. Before AstroZeneca, she worked as the scientific program manager for the Organs-on-Chips initiative at the National Center for Advancing Translational Sciences of the National Institute of Health (NIH).

Fabre received her bachelor’s degree in biology from the University of Wyoming, followed by her master’s degree and doctorate degree in cell and molecular biology from Colorado State University. She then served as a postdoctoral fellow in the radiation biology branch at the NIH National Cancer Institute.